PLEKHG1: New Potential Candidate Gene for Periventricular White Matter Abnormalities

Area of Science:

• Neuroscience
• Genetics
• Developmental Biology

Background:

• Periventricular leukomalacia (PVL) is a significant cause of neurological deficits like cerebral palsy, particularly in preterm infants.
• PVL results from compromised cerebral microcirculation, leading to oxygen deprivation in the brain's white matter.
• Known causes include preterm birth, cotwin demise, and genetic factors affecting GTPase pathways.

Purpose of the Study:

• To investigate the potential role of the PLEKHG1 gene in the pathogenesis of periventricular leukomalacia (PVL).
• To identify and characterize genetic variants associated with PVL.
• To explore the molecular mechanisms linking PLEKHG1 to white matter damage.

Main Methods:

• Whole exome sequencing (WES) was employed to identify genetic variants in a patient with PVL.
• In silico analyses were performed to predict the pathogenicity of the identified variant.
• Literature review and pathway analysis were used to understand the functional role of PLEKHG1 and CDC42.

Main Results:

• A de novo pathogenic variant in the PLEKHG1 gene was identified in a patient with PVL.
• PLEKHG1 encodes a Rho guanine nucleotide exchange factor crucial for CDC42 activation.
• The PLEKHG1-CDC42 pathway is implicated in endothelial cell responses to mechanical stress, potentially contributing to white matter lesions.

Conclusions:

• The identified de novo PLEKHG1 variant is a plausible contributor to PVL, expanding the genetic landscape of this condition.
• Disruption of the PLEKHG1-CDC42 pathway may underlie white matter damage in PVL.
• Further research is warranted to fully elucidate the role of PLEKHG1 in neonatal brain injury.